Article
Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice.
PloS one - 1 Jan 2013
Bot Martine, Van Veldhoven Paul P, de Jager Saskia C A, Johnson Jason, Nijstad Niels, Van Santbrink Peter J, Westra Marijke M, Van Der Hoeven Gerd, Gijbels Marion J, Müller-Tidow Carsten, Varga Georg, Tietge Uwe J F, Kuiper Johan, Van Berkel Theo J C, Nofer Jerzy-Roch, Bot Ilze, Biessen Erik A L
Abstract excerpt
AIMS: Altered sphingosine 1-phosphate (S1P) homeostasis and signaling is implicated in various inflammatory diseases including atherosclerosis. As S1P levels are tightly controlled by S1P lyase, we investigated the impact of hematopoietic S1P lyase (Sgpl1(-/-)) deficiency on leukocyte subsets relevant to atherosclerosis. METHODS AND RESULTS: LDL receptor deficient mice that were transplanted with Sgpl1(-/-) bone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
